Dec 31, 2013

Gilead Sciences Q4 2013 Earnings Report

Total Revenue
$3.12B
Previous year: $2.59B
+20.5%
EPS
$0.55
Previous year: $0.5
+10.0%
Gross Profit
$2.26B
Previous year: $1.91B
+18.3%
Cash and Equivalents
$2.11B
Previous year: $1.8B
+17.1%
Free Cash Flow
$593M
Total Assets
$22.6B
Previous year: $21.2B
+6.3%

Gilead Sciences

Gilead Sciences